Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-012-2 | CAS number: 137296-15-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In an acute oral toxicity study conducted according to OECD 420 and in an acute dermal toxicity study conducted according to OECD 402 young adult rats were exposed to the target substance. No mortality occurred after a single application of 2000 mg/kg bw in both studies within a 14 days observation period. Based on the results both the oral and the dermal LD50 exceed 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-05-18 to 2005-06-30
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Ammonium Lactate, PURASAL® NH
- Physical state: liquid
- Analytical purity: not reported
- Lot/batch No.: 0503002615
- Expiration date of the lot/batch: 2007-09-28
- Storage condition of test material: room temperature (20 +/- 5 °C) in the dark
- Other: Reception date: 2005-09-28 - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Interfauna Ibérica, S.L., Barcelona, Spain
- Age at study initiation: ca. 9 weeks (animals were ca. 8 weeks at arrival at the test facility and underwent a 7 day acclimatisation period prior to study initiation)
- Weight at study initiation: preliminary study (2 animals): 207 and 218 g; main study (5 animals): 206-221 g
- Fasting period before study: 17-18 h prior to administration
- Housing: Makrolon cages with Ultrasorb sawdust bedding (Panlab S.L.); each cage contained a maximum of 5 animals of the same sex and administration group; the sawdust bedding was replaced by a metal grille during the period of fasting previous to administration
- Identification of animals: individual indentification by code using an ear-punch technique
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24
- Humidity (%): 45-70
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Lot/batch no. (if required): 5133B02
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- Preliminary study:
The test item was administered orally to two females. Initially, one rat was treated at the dose of 300 mg/kg bw. As neither mortality nor clinical signs were observed in this animal, another animal was treated at the dose of 2000 mg/kg bw.
Main study:
Based on the information obtained in the preliminary study, and since neither mortality nor signs of toxicity were recorded in the female administered at the dose of 2000 mg/kg, the test item was administered orally at the dose of 2000 mg/kg bw to four more animals, making a group of five animals treated in the main study. - No. of animals per sex per dose:
- Preliminary study: 1 animal per dose (300 and 2000 mg/kg bw)
Main study: 5 animals per dose (2000 mg/kg bw) - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations:
* Preliminary study: observations at least twice daily
* Main study: at the day of administration the animals were observed frequently in order to record any possible clinical signs; afterwards the rats were observed at least twice daily for 14 days
- Weighing: before administration, daily on the three following days after treatment, weekly afterwards, and before sacrifice
- Necropsy of survivors performed: yes. At the end of the observation period, all the rats were sacrificed by intraperitoneal injection of sodium pentobarbital and then necropsies were performed on all the animals. This included the inspection of the intact animal and all superficial tissues,
followed by the observation of the viscera of the cranial, thoracic and abdominal cavities.
- Other examinations performed: changes in skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behaviour pattern in order to note any possible clinical response. - Statistics:
- Statistics were performed on body weight (mean weight and standard deviation; see Table 1).
- Preliminary study:
- Initially, one rat was treated at the dose of 300 mg/kg body weight. As neither mortality nor clinical signs were observed in this animal, another animal was treated at the dose of 2000 mg/kg bw. Piloerection was recorded in this animal from 3-4 hours after the administration. The presence of this clinical sign was not considered enough to confirm that the animal presented evident toxicity. This animal did not present clinical signs on the days following the treatment. No macroscopic alterations were recorded at the necropsies performed on the animals treated at the cited doses.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: None
- Gross pathology:
- No macroscopic alterations were detected during the necropsies done on the animals treated at the dose of 2000 mg/kg bw.
- Other findings:
- N.A.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute oral toxicity study conducted according to OECD guideline 420, rats were orally treated with the test item. Based on the results, the LD50 can be considered to be greater than 2000 mg/kg bw.
- Executive summary:
In an acute oral toxicity study conducted according to OECD guideline 420, five female Sprague Dawley SD rats were given a single oral dose of the test item in distilled water at a dose of 2000 mg/kg bw. The animals were observed for 14 days after the single exposure. No clinical signs and no mortalities occurred. Therefore, the oral LD50 can be considered to be greater than 2000 mg/kg bw.
Reference
Table 1: Body weight (g), main study
Dose level (mg/kg) |
Animal number |
Sex |
Day of the observation period |
Weight at necropsy |
|||||
0 |
1 |
2 |
3 |
7 |
14 |
||||
2000 |
2 |
F |
218 |
240 |
235 |
233 |
238 |
253 |
253 |
3 |
F |
221 |
244 |
246 |
248 |
258 |
265 |
265 |
|
4 |
F |
217 |
243 |
245 |
249 |
249 |
251 |
251 |
|
5 |
F |
206 |
222 |
226 |
226 |
228 |
238 |
238 |
|
6 |
F |
211 |
233 |
235 |
235 |
251 |
264 |
264 |
|
Mean |
214.6 |
236.4 |
237.4 |
238.2 |
244.8 |
254.2 |
254.2 |
||
SD |
6.02 |
9.13 |
8.26 |
9.98 |
11.82 |
11.03 |
11.03 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- GLP guideline study conducted according to OECD 420 conducted with the target substance.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-03-10 to 2005-07-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- Name of test material (as cited in study report): Ammonium Lactate, PURASAL® NH
- Physical state: yellowish-white liquid
- Analytical purity: not reported
- Lot/batch No.: 0503002615
- Expiration date of the lot/batch: 2007-09-28
- Storage condition of test material: room temperature (20 +/- 5 °C) in the dark
- Other: Reception date: 2005-04-01 - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Interfauna Ibérica, S.L., Barcelona, Spain
- Age at study initiation: ca. 7-8 weeks
- Weight at arrival: 143-194 g
- Weight at study initiation: preliminary study: 215-233 g; main study: 212-235 g (males) and 200-221 g (females)
- Fasting period before study: 17-18 h prior to administration
- Housing: Makrolon cages with Ultrasorb sawdust bedding (Panlab S.L.); each cage contained up to 4 animals of the same sex; at the time of administration the rats were placed in individual cages with a grille floor to avoid contact with the sawdust or any other material that could cause cutaneous irritation.
- Identification of animals: individual indentification by code using an ear-punch technique
- Diet (e.g. ad libitum): standard rat diet, ad libitum
- Water (e.g. ad libitum): distilled water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24
- Humidity (%): 50-70
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12/12 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: ca. 24 hours before administration of the test item the back of each animal was shaved using an electric razor, from the scapula area to the lumbar region. the test item at a 100% concentration was placed on approximately 6.0 x 4.0 cm squares of hydrophillic gauze and applied to the corresponding test area.
- % coverage: 10% of the total body surface area.
- Type of wrap if used: The gauze was covered with a hypoallergenic microporous adhesive band. Finally, a strip of gauze was wrapped around the trunk of the rat in order to hold the patches in place. The band was fixed to the body of the animal using adhesive tape.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, with distilled water
- Time after start of exposure: 24 h
TEST MATERIAL
- Concentration (if solution): 100%
- Dose: 2000 mg/kg bw; the amount of the test item administered to each animal was calculated taking into account its body weight at the time of administration. - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- - Preliminary study: two male and two female rats per dose (2000 mg/kg bw)
- Main study: five male and five female rats per dose (2000 mg/kg bw) - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration in preliminary and main study: 14 days
- Frequency of observations: twice daily
- Frequency of weighing: all rats were weighed before administration, halfway through the observation period, and before sacrifice
- Necropsy of survivors performed: yes (only animals of the main study)
- Other examinations performed: observations included, but were not limited to, changes in skin or fur, eyes and mucous membranes, respiratory, circulatory, central nervous and autonomic nervous systems, somatomotor activity and behaviour, in order to record any clinical response
- Sacrifice and postmortem procedures: at the end of the observation period, all the rats were sacrificed by intraperitoneal injection of sodium pentobarbital and then necropsies were performed on all the animals of the main study. The necropsy included a revision of the intact animal and all its superficial tissues, followed by an observation of the cranial, thoracic and abdominal cavities. - Statistics:
- Statistics were performed on body weight (mean weight and standard deviation; see table 1)
- Preliminary study:
- No mortality was recorded among the animals from the preliminary study (two males and two females) treated at the dose of 2000 mg/kg bw.
No clinical signs were recorded in any of the animals administered in the preliminary study on the day of administration nor on the following days.
No dermal alterations were recorded in any of the animals on removing the semi-occlusive patches.
The body-weight evolution in the treated males was normal. In the two females, a body-weight loss of 3 and 8 g, respectively, was recorded between the day of administration and day 7 of the observation period. In both cases, the animals regained weight. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There was no mortality among the animals (5 males and 5 females) treated at the dose of 2000 mg/kg.
- Clinical signs:
- other: No clinical signs were recorded in any of the animals administered at the dose of 2000 mg/kg bw on the day of treatment nor during the observation period. No dermal alterations were recorded in any of the animals on removal of the semi-occlusive patches a
- Gross pathology:
- No macroscopic alterations were recorded in the necropsies done on all the animals from the main study.
- Other findings:
- N.A.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute dermal toxicity study conducted according to OECD guideline 402 rats were dermally treated with the test item. Based on the results, the LD50 can be considered to be greater than 2000 mg/kg bw.
- Executive summary:
In an acute dermal toxicity study (OECD 402, limit test), a group of young adult Sprague Dawley rats (5 males and 5 females) were dermally exposed to the test item (liquid, 100% concentration) for 24 hours to approximately 10% of body surface area at 2000 mg/kg bw. Animals were observed for 14 days. No mortality occurred. There were no treatment related clinical signs, necropsy findings or changes in body weight. The dermal LD50 value of the test item in both female and male Sprague Dawley rats was established to exceed 2000 mg/kg body weight.
Reference
Table 1: Body weight (g), main study
Dose level (mg/kg) |
Animal number |
Sex |
Day |
Weights at necropsy |
||
0 |
7 |
10 |
||||
2000 |
5 |
M |
212 |
243 |
274 |
274 |
6 |
M |
217 |
245 |
268 |
268 |
|
7 |
M |
230 |
262 |
293 |
293 |
|
8 |
M |
224 |
260 |
292 |
292 |
|
9 |
M |
235 |
268 |
299 |
299 |
|
Mean |
223.6 |
255.6 |
285.2 |
285.2 |
||
SD |
9.34 |
11.01 |
13.41 |
13.41 |
||
10 |
F |
219 |
228 |
246 |
246 |
|
11 |
F |
203 |
211 |
224 |
224 |
|
12 |
F |
221 |
233 |
252 |
252 |
|
13 |
F |
200 |
209 |
223 |
223 |
|
14 |
F |
206 |
215 |
229 |
229 |
|
Mean |
209.8 |
219.2 |
234.8 |
234.8 |
||
SD |
9.58 |
10.69 |
13.33 |
13.33 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- GLP guideline study conducted according to OECD 402 conducted with the target substance.
Additional information
Data from two acute toxicity studies conducted with the target substance are available. In an acute dermal toxicity study (OECD 402, limit test), a group of young adult Sprague Dawley rats (5 animals per sex) were dermally exposed to the target substance for 24 hours to approximately 10% of body surface area at 2000 mg/kg bw. Animals were observed for 14 days. No mortality occurred and the LD50 was considered to exceed 2000 mg/kg bw.
Furthermore, in an acute oral toxicity study conducted according to OECD guideline 420 five female Sprague Dawley SD rats were given a single oral dose of the target substance at a dose of 2000 mg/kg bw. The animals were observed for 14 days and no clinical signs and/or mortalities occurred. Therefore, the oral LD50 can be considered to be greater than 2000 mg/kg bw.
Justification for classification or non-classification
Based on the available data the target substance does not warrant classification for acute toxicity. The LD50 values for both the dermal and the oral route are above the limit dose of 2000 mg/kg bw of CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.